- Datum21.04.2025
- Uhrzeit19:00 - 20:00 Uhr
- Veranstalter
BNP Paribas
Accelerate Diagnostics Inc. Aktie
Verkaufen
Kaufen
Accelerate Diagnostics Inc. Chart
Accelerate Diagnostics Inc. Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
-1,81 %
Intraday
-1,96 %
1 Woche
-50,54 %
1 Monat
-54,25 %
Seit Jahresbeginn
-36,09 %
1 Jahr
-94,82 %
3 Jahre
-99,42 %
5 Jahre
-99,75 %
10 Jahre
Passender Service zu Accelerate Diagnostics Inc.
Webinar zu Accelerate Diagnostics Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)0,490-2,090
- Jahrestief / Hoch ($)0,490-1,400
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Accelerate Diagnostics Inc.
Keine Dividenden verfügbar
Termine von Accelerate Diagnostics Inc.
Keine aktuellen Termine
Beschreibung
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
